Your browser doesn't support javascript.
loading
MRI for nodal restaging after neoadjuvant therapy in rectal cancer with histopathologic comparison.
Zhang, Zhiwen; Chen, Yan; Wen, Ziqiang; Wu, Xuehan; Que, Yutao; Ma, Yuru; Wu, Yunzhu; Liu, Quanmeng; Fan, Wenjie; Yu, Shenping.
Afiliação
  • Zhang Z; Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, 510080, Guangzhou, China.
  • Chen Y; Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, 510080, Guangzhou, China.
  • Wen Z; Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, 510080, Guangzhou, China.
  • Wu X; Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, 510080, Guangzhou, China.
  • Que Y; Department of Radiology, The Seventh Affiliated Hospital, Sun Yat-sen University, 518036, Shenzhen, China.
  • Ma Y; Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, 510080, Guangzhou, China.
  • Wu Y; Department of Radiology, The Seventh Affiliated Hospital, Sun Yat-sen University, 518036, Shenzhen, China.
  • Liu Q; Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, 510080, Guangzhou, China.
  • Fan W; MR Scientific Marketing, SIEMENS Healthineers Ltd, 200124, Shanghai, China.
  • Yu S; Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, 510080, Guangzhou, China.
Cancer Imaging ; 23(1): 67, 2023 Jul 13.
Article em En | MEDLINE | ID: mdl-37443085
ABSTRACT

BACKGROUND:

After neoadjuvant therapy, most of the lymph nodes (LNs) will shrink and disappear in patients with rectal cancer. However, LNs that are still detectable on MRI carry a risk of metastasis. This study aimed to evaluate the performance of the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) criterion (short-axis diameter ≥ 5 mm) in diagnosing malignant LNs in patients with rectal cancer after neoadjuvant therapy, and whether nodal morphological characteristics (including shape, border, signal homogeneity, and enhancement homogeneity) could improve the diagnostic efficiency for LNs ≥ 5 mm.

METHODS:

This retrospective study included 90 patients with locally advanced rectal cancer who underwent surgery after neoadjuvant therapy and performed preoperative MRI. Two radiologists independently measured the short-axis diameter of LNs and evaluated the morphological characteristics of LNs ≥ 5 mm in consensus. With a per node comparison with histopathology as the reference standard, a ROC curve was performed to evaluate the diagnostic performance of the size criterion. For categorical variables, either a χ2 test or Fisher's exact test was used.

RESULTS:

A total of 298 LNs were evaluated. The AUC for nodal size in determining nodal status was 0.81. With a size cutoff value of 5 mm, the sensitivity, specificity, positive predictive value, negative predictive value and accuracy were 65.9%, 87.0%, 46.8%, 93.6% and 83.9%, respectively. No significant differences were observed in any of the morphological characteristics between benign and malignant LNs ≥ 5 mm (all P > 0.05).

CONCLUSIONS:

The ESGAR criterion demonstrated moderate diagnostic performance in identifying malignant LNs in patients with rectal cancer after neoadjuvant therapy. It was effective in determining the status of LNs < 5 mm but not for LNs ≥ 5 mm, and the diagnostic efficiency could not be improved by considering nodal morphological characteristics.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Terapia Neoadjuvante Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Imaging Assunto da revista: DIAGNOSTICO POR IMAGEM / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Terapia Neoadjuvante Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Imaging Assunto da revista: DIAGNOSTICO POR IMAGEM / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China